Full CoverageTop news
Hims & Hers stock plummets after Novo Nordisk ends Wegovy direct sales deal
By Anjalee Khemlani
Novo Exits Hims Partnership, Citing Concerns Over Compounded Drugs
By Naomi Kresge & Madison Muller
Novo Nordisk terminates collaboration with Hims & Hers Health, Inc. due to concerns about their illegal mass compounding and deceptive marketing
All coverage
Novo ends partnership with Hims & Hers over compounding concerns
By Katherine Davis
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 28%
By Annika Kim Constantino
Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.
By Steve Gelsi
Hims & Hers Stock Plunges as Novo Nordisk Abruptly Ends Partnership
By Josh Nathan-kazis & Mackenzie Tatananni
Hims & Hers on track for biggest drop ever after Novo Nordisk ends partnership
By J. Edward Moreno Del Angel
IBD 50's Hims Plummets After Novo Yanks Deal Over 'Deceptive' And 'Illegitimate' Wegovy Knockoffs
By Allison Gatlin
Novo Nordisk, Hims and Hers Shares Tumble on Severed Ties
By Fernanda Horner
Novo abruptly ends obesity drug deal with Hims
By Jonathan Gardner
Plainsboro-Based Wegovy Provider Ends Hims & Hers Deal Over Knockoff Weight-Loss Drug Sales
By Chris Spiker
Novo Nordisk Ends Hims & Hers Collaboration Over Wegovy Weight Loss Drug
By Catherine Evans, Terje Solsvik & Bhanvi Satija
Hims & Hers stock falls after healthcare company cuts ties
By Spencer Gustafson
Hims & Hers Stock (HIMS) Collapses 30% After Novo Nordisk Pulls Wegovy Deal on Safety Fears
By David Craik
Why Did HIMS Shares Crash Today? Novo Nordisk Terminates Deal Over "Deceptive" Practices
By Tim Fries
Hims & Hers Health Stock Is Tumbling Monday: What's Happening?
By Adam Charles Eckert
Hims Crashes After Novo Unexpectedly Yanks Collaboration Deal
By Allison Gatlin
Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 20%
By Annika Kim Constantino
Hims & Hers Goes Global, Named To Top Stocks List: Build Your Growth Stock Watchlist With These Just Updated Screens
By James DeTar
Novo Nordisk ends Hims & Hers collaboration over Wegovy weight loss drug
By Catherine Evans, Terje Solsvik & Bhanvi Satija
Hims & Hers shares drop after Novo Nordisk ends Wegovy collaboration over compounding practices
By Angela Harmantas
Novo ends short-lived partnership with Hims over compounded obesity drugs
By Shelby Livingston